JAMA Network Home
Sign In
Comment & Response

Reassessing Utility in the MyLungHealth Trial—Reply

JAMA Oncology 10.1001/jamaoncol.2026.0545

April 02, 2026 at 11:00 AM EDT

Read the full article

Corresponding Author: Kensaku Kawamoto, MD, PhD, MHS, Department of Biomedical Informatics, University of Utah, 421 Wakara Way, Ste 108, Salt Lake City, UT 84108 (kensaku.kawamoto@utah.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2026.0545?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040226

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks